Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shoei Yakuhin Co.,Ltd. (3537.T)
Osaka, JP
Shoei Yakuhin Co.,Ltd., established in 1937 and based in Osaka, Japan, operates as a global trading company with a presence in Japan, China, Thailand, and Singapore. The firm specializes in distributing a wide array of products across three main categories: chemicals, everyday consumer goods, and civil engineering/construction materials. Its chemical portfolio includes oleochemicals, surfactants, solvents, mineral oils, synthetic resins, anti-termite treatments, and petrochemicals. The company also supplies an extensive range of daily necessities such as household and commercial detergents, cosmetics, soaps, shampoos, cleaning agents, insect repellents, sterilization products, desiccants, air fresheners, deodorizers, waxes, polishing agents, functional insoles, various household repair solutions, and other molded products. Additionally, Shoei Yakuhin provides essential civil engineering and construction materials, including ground improvement substances, structural repair and reinforcement materials, environmental remediation compounds, and other construction-related supplies.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.53% | +3.68% | +5.66% | +4.47% | +9.28% | +6.68% | -3.37% | +71.06% | +67.95% | +97.35% | +99.24% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+7.6% ★ Q1'26: +8.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+5.3% Q1'26: +112.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+1.9% Q1'26: +1.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.8% Q1'26: +5.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.4% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.29× ★ Q1'26: 0.32× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2016 actual |
Mar 2017 actual |
|---|---|---|
| Revenue |
18.41B
est: 18.60B (-1.0%)
|
18.83B
est: 19.40B (-2.9%)
|
| EBITDA |
295.39M
est: 557.29M (-47.0%)
|
335.09M
est: 581.25M (-42.4%)
|
| EBIT |
283.36M
est: 541.86M (-47.7%)
|
323.09M
est: 565.17M (-42.8%)
|
| Net Income |
759.07M
est: 932.26M (-18.6%)
|
261.49M
est: 267.14M (-2.1%)
|
| SGA |
1.25B
est: 1.20B (+3.8%)
|
1.23B
est: 1.25B (-1.6%)
|
| EPS |
261.69
est: 273.60 (-4.4%)
|
73.06
est: 78.40 (-6.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hideyuki Nishio | GM of Sales Division 2 & Director | — | male |
| Hiromi Koike | GM of General Affairs Division & Director | — | male |
| Hisaaki Nishikage | Director & First Deputy General Manager of Sales Division | — | male |
| Katsuya Uchida | GM of Sales Division 1 & Director | — | male |
| Koji Naruse | MD, GM of Finance Division & Director | — | male |
| Saichiro Fujiwara | President & Chairperson | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3537.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
